AI-generated summary
In this study in rats with a photothrombotic model of ischemic stroke, the authors report that daily red-to-near-infrared light therapy at 808 nm over the infarct area reduced behavioral deficits and infarct volume. They also report increased markers of neurogenesis and synaptogenesis and changes in inflammation and mitochondrial function, which they associate with neuronal repair. Findings come from an animal study.
- Who or what was studied
- Rats with a photothrombotic model of ischemic stroke
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The abstract describes an animal study, and it does not state a sample size or whether a control group was used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808nm
- Power density (irradiance)
- 350mW/cm2
- Total energy
- 294J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Stroke, Photobiomodulation therapy, Adenosine triphosphate, Cytochrome c oxidase. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.